BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 25187512)

  • 21. Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study.
    Orozco L; Soler R; Morera C; Alberca M; Sánchez A; García-Sancho J
    Transplantation; 2011 Oct; 92(7):822-8. PubMed ID: 21792091
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intradiscal interventional therapy for degenerative chronic discogenic low back pain with end-plate Modic changes].
    Zhuang CY; Cao P; Zheng T; Yang YQ; Zhang ZW; Chen W
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2490-4. PubMed ID: 20137437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isolation and characterization of mesenchymal stromal cells from human degenerated nucleus pulposus: comparison with bone marrow mesenchymal stromal cells from the same subjects.
    Blanco JF; Graciani IF; Sanchez-Guijo FM; Muntión S; Hernandez-Campo P; Santamaria C; Carrancio S; Barbado MV; Cruz G; Gutierrez-Cosío S; Herrero C; San Miguel JF; Briñon JG; del Cañizo MC
    Spine (Phila Pa 1976); 2010 Dec; 35(26):2259-65. PubMed ID: 20622750
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Local transplantation of bone marrow concentrated granulocytes precursors can cure without antibiotics infected nonunion of polytraumatic patients in absence of bone defect.
    Hernigou P; Trousselier M; Roubineau F; Bouthors C; Chevallier N; Rouard H; Flouzat-Lachaniette CH
    Int Orthop; 2016 Nov; 40(11):2331-2338. PubMed ID: 26928724
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systematic Review: Is Intradiscal Injection of Bone Marrow Concentrate for Lumbar Disc Degeneration Effective?
    Hirase T; Jack RA; Sochacki KR; Harris JD; Weiner BK
    Cureus; 2020 Jul; 12(7):e9045. PubMed ID: 32782864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Success of lumbar microdiscectomy in patients with modic changes and low-back pain: a prospective pilot study.
    Chin KR; Tomlinson DT; Auerbach JD; Shatsky JB; Deirmengian CA
    J Spinal Disord Tech; 2008 Apr; 21(2):139-44. PubMed ID: 18391720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous bone marrow concentrate: review and application of a novel intra-articular orthobiologic for cartilage disease.
    Sampson S; Botto-van Bemden A; Aufiero D
    Phys Sportsmed; 2013 Sep; 41(3):7-18. PubMed ID: 24113698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD34(+) hematopoietic progenitor cell selection of bone marrow grafts for autologous transplantation in pediatric patients.
    Kasow KA; Sims-Poston L; Eldridge P; Hale GA
    Biol Blood Marrow Transplant; 2007 May; 13(5):608-14. PubMed ID: 17448921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial.
    Lee DH; Park KS; Shin HE; Kim SB; Choi H; An SB; Choi H; Kim JP; Han I
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of age on outcomes after allogeneic disc tissue supplementation in patients with chronic discogenic low back pain in the VAST trial.
    Hunter CW; Guyer R; Froimson M; DePalma MJ
    Pain Manag; 2022 Apr; 12(3):301-311. PubMed ID: 34875850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of regenerative treatments in treatment of lumbar Degenerative Disc Disease: A systematic review.
    Yolcu YU; Moinuddin FM; Wahood W; Alvi MA; Qu W; Bydon M
    Clin Neurol Neurosurg; 2020 Aug; 195():105916. PubMed ID: 32442808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical outcome of lumbar total disc replacement using ProDisc-L in degenerative disc disease: minimum 5-year follow-up results at a single institute.
    Park CK; Ryu KS; Lee KY; Lee HJ
    Spine (Phila Pa 1976); 2012 Apr; 37(8):672-7. PubMed ID: 21857395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of the Wallis interspinous implant to lower the incidence of recurrent lumbar disc herniations in patients undergoing primary disc excision.
    Floman Y; Millgram MA; Smorgick Y; Rand N; Ashkenazi E
    J Spinal Disord Tech; 2007 Jul; 20(5):337-41. PubMed ID: 17607096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Percutaneous epidural lysis of adhesions in chronic lumbar radicular pain: a randomized, double-blind, placebo-controlled trial.
    Gerdesmeyer L; Wagenpfeil S; Birkenmaier C; Veihelmann A; Hauschild M; Wagner K; Muderis MA; Gollwitzer H; Diehl P; Toepfer A
    Pain Physician; 2013; 16(3):185-96. PubMed ID: 23703406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low Back Pain, Disability, and Quality of Life One Year following Intradiscal Injection of Autologous Bone Marrow Aspirate Concentrate.
    Haines CM; Bhatt FR; Orosz LD; Yamout T; Namian S; Bharara N; Bucci A; Schuler TC; Jazini E; Good CR
    Stem Cells Int; 2022; 2022():9617511. PubMed ID: 36579141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dynesys dynamic stabilization system for the lumbar degenerative disease: a preliminary report from China.
    Li HP; Li F; Guan K; Zhao GM; Shan JL; Sun TS
    Chin Med J (Engl); 2013 Nov; 126(22):4265-9. PubMed ID: 24238510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective, randomized, multicenter Food and Drug Administration investigational device exemption study of lumbar total disc replacement with the CHARITE artificial disc versus lumbar fusion: five-year follow-up.
    Guyer RD; McAfee PC; Banco RJ; Bitan FD; Cappuccino A; Geisler FH; Hochschuler SH; Holt RT; Jenis LG; Majd ME; Regan JJ; Tromanhauser SG; Wong DC; Blumenthal SL
    Spine J; 2009 May; 9(5):374-86. PubMed ID: 18805066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Natural history and prognosis of discogenic low back pain].
    Peng BG; Pang XD; Li DM; Zhang XY; Kuang ZD; Du MK; Gao CH
    Zhonghua Yi Xue Za Zhi; 2009 Aug; 89(31):2171-4. PubMed ID: 20058592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.